Welcome to CDC Stacks | The Urgent threat of TB drug resistance : drug resistant TB threatens to erase decades of progress - 41769 | Stephen B. Thacker CDC Library collection
Stacks Logo
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
Help
Clear All Simple Search
Advanced Search
The Urgent threat of TB drug resistance : drug resistant TB threatens to erase decades of progress
  • Published Date:
    August 2016
  • Language:
    English
Filetype[PDF - 601.78 KB]


Details:
  • Corporate Authors:
    National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (U.S.). Division of Tuberculosis Elimination.
  • Description:
    One-third of the world’s population is infected with TB, and 10.4 million people become sick with active TB disease each year. TB is among the leading causes of death from infectious disease globally and claims 1.8 million lives each year, even though we have had a cure for more than 70 years. In some cases of TB, the bacteria that causes infection has been able to develop resistance to the anti-TB drugs used to cure it. Most often, this stems from incomplete treatment of non- resistant TB. In recent decades, these strains have become resistant to more and more of our best drugs and continue to spread globally. Drug-resistant TB strains are more difficult to cure and costly to our economy and health system. Because TB is airborne and contagious, the continued spread of drug-resistant TB could cause a resurgence of TB in parts of the world where TB is currently less common, including the United States.

    dght_mdr-tb_factsheet_10-14-2016_ck_v3.pdf

  • Supporting Files:
    No Additional Files